Table 1 Summary of all participants

From: Increased circulating cell signalling phosphoproteins in sera are useful for the detection of pancreatic cancer

Experimental groups (number of patients)

Sex (M/F)

Age (mean±s.d.)

Training set (n=51)

 Pancreatic cancer (n=26)

17/9

65.2±8.0

 Healthy volunteer (n=25)

17/8

52.0±10.6

Validation set 1 (n=148)

 Pancreatic cancer (n=80)

48/32

62.9±10.8

 Healthy volunteer (n=68)

41/27

54.1±6.8

Validation set 2 (n=123)

 Pancreatic cancer (n=35)

21/14

63.6±8.8

 Pancreatitis (n=40)

38/2

61.7±8.8

 Healthy volunteer (n=48)

32/16

62.4±7.3

  1. Abbreviations: F=female; M=male.